SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from ACHIEVE LIFE SCIENCES, INC. (ACHV) (CIK 0000949858) (ACHV) — Feb 7, 2019

ACHIEVE LIFE SCIENCES, INC. (ACHV) (CIK 0000949858)
Date: Feb. 7, 2019 · CIK: 0000949858 · Accession: 0001193125-19-030511

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-229019

Date
February 7, 2019
Author
By
Form
CORRESP
Company
ACHIEVE LIFE SCIENCES, INC. (ACHV) (CIK 0000949858)

Letter

ACHIEVE LIFE SCIENCES, INC.

1040 West Georgia Street, Suite 1030

Vancouver, British Columbia, Canada V6E 4H1

February 7, 2019

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C.

Attention:

Robert Errett

Re:

Achieve Life Sciences, Inc. Registration Statement on Form S-3

Filed December 26, 2018 (File No. 333-229019)

Requested Date:

February 11, 2019

Requested Time:

4:30 p.m. Eastern Time

Ladies and Gentlemen:

Achieve Life Sciences, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to make the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.

The Registrant hereby authorizes Alan Smith or Amanda Rose, both of whom are attorneys with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.

The Registrant requests that it be notified of such effectiveness by a telephone call to Ms. Rose at (206) 389-4553, or in her absence, Mr. Smith at (206) 389-4530.

Sincerely,
ACHIEVE LIFE SCIENCES, INC.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 ACHIEVE LIFE SCIENCES, INC.

1040 West Georgia Street, Suite 1030

Vancouver, British Columbia, Canada V6E 4H1

February 7, 2019

 VIA EDGAR

 U.S. Securities and Exchange Commission

 Division
of Corporation Finance

 100 F Street, N.E.

 Washington, D.C.
20549

Attention:

Robert Errett

Re:

Achieve Life Sciences, Inc. Registration Statement on Form S-3

Filed December 26, 2018 (File No. 333-229019)

Requested Date:

February 11, 2019

Requested Time:

4:30 p.m. Eastern Time

 Ladies and Gentlemen:

 Achieve
Life Sciences, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to make the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.

The Registrant hereby authorizes Alan Smith or Amanda Rose, both of whom are attorneys with the Registrant’s outside legal counsel, Fenwick &
West LLP, to orally modify or withdraw this request for acceleration.

 The Registrant requests that it be notified of such effectiveness by a
telephone call to Ms. Rose at (206) 389-4553, or in her absence, Mr. Smith at (206) 389-4530.

Sincerely,

ACHIEVE LIFE SCIENCES, INC.

By:

 /s/ John Bencich

John Bencich

Chief Financial Officer